The European Medicines Agency (EMA) has published a press release introducing new regulations and requirements for paediatric trials. These regulations are aimed, in particular, at encouraging the development of new treatment options for child patients. The EMA has developed various strategies to provide greater transparency and collaboration in the process of developing and implementing paediatric investigation plans (PIPs).
The new regulations include specific criteria and guidelines designed to ensure that trial sites meet the ethical and scientific standards required for paediatric trials. In addition, these regulations aim to increase children's participation in clinical trials and to ensure that families are kept informed throughout the process.
Implications for the Turkish Clinical Trials Sector and Sponsors:
The impact of these new regulations on the clinical trials sector and sponsors in Türkiye is highly significant. With its geographical location and advanced healthcare infrastructure, Türkiye has become an attractive market for clinical trials. The new regulations introduced by the EMA for paediatric trials will encourage Turkish trial sites to align with international standards and to conduct more paediatric trials.
Under these new regulations, sponsors will need to be provided with guidance on exercising greater care during the planning and conduct stages of paediatric trials and on obtaining the necessary ethics approvals. Moreover, the development of safe and effective treatment options for child patients will enhance the quality of clinical trials in Türkiye and strengthen international collaborations.
As Omega CRO, with our 29 years of experience, we provide comprehensive support to our sponsors in adapting to regulatory developments of this kind. Our HelixLab and Omega Genetics laboratories perform the analyses required to enhance the reliability of trials, while through OmegaCare we offer home healthcare services that facilitate patient participation. In addition, with our advanced technologies such as TURP and IWRS, we optimise data management and trial processes.
We recommend that sponsors contact us to ensure compliance with these new regulations and to increase the success of their paediatric trials. Omega CRO is at your side to take your clinical trials to the next level.